Form D · Biotechnology
GENVEC INC
Gaithersburg, MD · CIK 0000934473
Offering snapshot reported Jan 28, 2010 · SEC filing
- Reported sold
- $2M Offering amount: $2M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $2M Reported outside-investor minimum
- First sale
- Jan 13, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 28, 2010 | Initial | $1,999,999 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-93447-3P
Source: Form D, filed Jan 28, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Paul H. Fischer | Director, Executive |
| Wayne T. Hockmeyer | Director |
| Zola P. Horovitz | Director |
| William N. Kelley | Director |
| Kevin M. Rooney | Director |
| Joshua Ruch | Director |
| Marc Schneebaum | Director |
| Douglas J. Swirsky | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
65 West Watkins Mill Road
Gaithersburg, MD, 20878
Gaithersburg, MD, 20878